Carfizome 60mg Injection

About

Carfizome 60mg Injection is a targeted antineoplastic agent, specifically a proteasome inhibitor, used in the treatment of certain hematological malignancies. It works by selectively inhibiting the proteasome, a cellular complex responsible for degrading proteins. By blocking the proteasome, Carfizome disrupts various cellular processes, including cell cycle progression, apoptosis, and gene expression, leading to the accumulation of misfolded proteins and ultimately inducing programmed cell death in cancer cells. This mechanism makes it particularly effective against multiple myeloma, especially in patients who have relapsed or are refractory to previous therapies. Administered intravenously under the supervision of an experienced oncologist, Carfizome offers a crucial treatment option for patients with advanced disease, aiming to improve progression-free survival and overall response rates. Close monitoring for potential side effects is essential throughout the treatment course.

Uses

• Treatment of relapsed or refractory multiple myeloma
• Used as part of combination regimens for multiple myeloma
• For patients who have received prior therapies for multiple myeloma
• In cases where other treatments have been ineffective

Directions For Use

Administer intravenously under the supervision of a qualified healthcare professional experienced in oncology. Dosage and schedule are determined by the treating physician.

Benefits

• Targets specific cancer pathways, leading to selective cell death
• Effective in cases of relapsed or refractory multiple myeloma
• Improves progression-free survival in treated patients
• Part of advanced and established treatment protocols
• Helps reduce tumor burden and control disease progression
• Offers new treatment options for challenging cases

Side Effects

• Fatigue
• Nausea
• Diarrhea
• Thrombocytopenia (low platelet count)
• Anemia (low red blood cell count)
• Peripheral neuropathy
• Dyspnea (shortness of breath)
• Hypertension (high blood pressure)
• Cardiac events (e.g., heart failure)
• Infusion-related reactions
• Fever
• Skin rash

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may worsen fatigue or liver-related side effects.
• Pregnancy - Contraindicated; can cause fetal harm. Advise women of reproductive potential to use effective contraception during and after treatment.
• Breastfeeding - Contraindicated; unknown if excreted in human milk, but potential for serious adverse reactions in breastfed infants.
• Liver - Use with caution in patients with hepatic impairment; dose adjustment may be required, and liver function should be monitored.
• Kidney - Use with caution in patients with renal impairment; dose adjustment may be required, and renal function should be monitored.
• Lung - Monitor for pulmonary hypertension and other lung toxicities, especially in patients with pre-existing cardiac or pulmonary conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.